✓ Credit card payment restored — secure checkout via Privacy Shield

Minirin Nasal Spray

✅ Controls excessive urination
✅ Manages bedwetting
✅ Treats diabetes insipidus
✅ Reduces nocturia
✅ Prevents dehydration

Minirin Nasal Spray contains Desmopressin.

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per vial
1 Vial/s
US$21.00/vial
US$21.00
2 Vial/s
US$19.00/vial · save 10%
US$38.00
3 Vial/s
US$18.00/vial · save 14%
US$54.00
6 Vial/s BEST VALUE
US$17.33/vial · save 17%
US$104.00
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer — What is Minirin Nasal Spray?

Minirin Nasal Spray is a intranasal spray of desmopressin (0.1 mg/mL intranasal) — a synthetic analogue of the natural antidiuretic hormone (vasopressin). It is used for central diabetes insipidus (the pituitary disorder, NOT the common type 2 diabetes mellitus), primary nocturnal enuresis (bedwetting), and nocturia. Desmopressin reduces urine production by up to 90% by promoting water reabsorption in the collecting ducts of the kidney. Onset: 15–30 minutes; duration: 6–12 hours. Critical safety rule — restrict fluids for 1 hour before and 8 hours after each dose to prevent dangerous hyponatraemia (low sodium, which can cause seizures). Avoid in heart failure, moderate-to-severe renal impairment, hyponatraemia, and SIADH. Desmopressin is NOT a treatment for type 2 diabetes or insulin resistance — the two conditions share only the word “diabetes”.

What you get with MedsBase: WHO-GMP certified manufacturer · Discreet packaging · Worldwide shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

📅 Why order Minirin Nasal Spray from MedsBase? Genuine Ferring Pharmaceuticals manufacturer stock · discreet packaging · worldwide shipping · 1,400+ customers across 50+ countries · 4.9★ rated. Read customer reviews.

What Is Minirin Nasal Spray?

Minirin Nasal Spray is a intranasal spray formulation of desmopressin acetate (0.1 mg/mL intranasal), manufactured by Ferring Pharmaceuticals. Supplied in packs of 1 or 3 bottles (2.5 mL each).

Desmopressin (DDAVP) is a synthetic analogue of arginine vasopressin (ADH), the body’s natural antidiuretic hormone. It has been modified in two ways: a deamination at position 1 (increasing resistance to enzymatic breakdown) and substitution of L-arginine with D-arginine at position 8 (removing the vasoconstrictor effect). The result is a drug with strong antidiuretic action but minimal blood-pressure effects.

What Is Minirin Nasal Spray Used For?

Desmopressin is approved for three main groups of conditions:

  • Central diabetes insipidus — caused by ADH deficiency (often from a pituitary tumour, surgery, or head trauma). Patients pass 3–20 litres of dilute urine per day and are chronically thirsty. Desmopressin replaces the missing hormone.
  • Primary nocturnal enuresis (bedwetting) — in children aged 6 and over, and in adults with persistent bedwetting. Reduces overnight urine production.
  • Nocturia (adult) — waking at night to pass urine, where fluid restriction and other measures have failed.

Off-label: mild haemophilia A and type 1 von Willebrand disease (raises factor VIII and von Willebrand factor levels short-term), uraemic bleeding before procedures.

Is Desmopressin for Type 2 Diabetes?

No. “Diabetes insipidus” and “diabetes mellitus” share the Latin word diabetes (meaning “to pass through” — referring to excess urine output) but are completely different conditions:

  • Diabetes mellitus (type 1 and type 2) — a problem with insulin and blood glucose. Treated with metformin, SGLT-2 inhibitors, GLP-1 agonists, sulfonylureas, insulin, etc.
  • Diabetes insipidus — a problem with the antidiuretic hormone (either deficiency from the pituitary, or kidney resistance). Treated with desmopressin (central form) or thiazide diuretics / amiloride (nephrogenic form).

If you are looking for a medicine to lower blood sugar, please see the metformin, SGLT-2, or DPP-4 product pages instead.

How Does Minirin Nasal Spray Work?

Desmopressin binds to V2 receptors on cells lining the collecting ducts of the kidney. This triggers insertion of aquaporin-2 water channels into the cell membrane, allowing water to be reabsorbed from urine back into the blood. Urine output falls and urine concentration rises.

In central diabetes insipidus, this replaces the missing hormone. In primary nocturnal enuresis and nocturia, it reduces the volume of urine produced overnight — so the bladder does not fill to the point of leakage or waking.

Desmopressin has essentially no effect on V1 receptors, which means it does not cause vasoconstriction or raise blood pressure (unlike natural vasopressin).

Dosage and Administration

Central diabetes insipidus (adults): 10–20 µg (1–2 sprays) intranasally once or twice daily. Children: 5–10 µg intranasally once or twice daily, titrated to response.

Primary nocturnal enuresis: 10–20 µg intranasally at bedtime (only where tablets are not suitable). Note: the FDA removed the intranasal formulation’s approval for bedwetting in 2007 due to hyponatraemia concerns; tablets are preferred for enuresis.

Haemophilia A / von Willebrand disease (off-label bleeding prophylaxis): specialist use; dose individualised.

  • Prime the pump — spray 4 times into the air if new, or if not used for > 24 hours, until a fine mist is seen.
  • Blow your nose gently before dosing.
  • Hold the bottle upright, insert the tip into a nostril, and spray once as you inhale slowly through the nose.
  • Avoid sniffing too hard — the medicine should stay in the nasal passages, not run down the throat.
  • Fluid restriction from 1 hour before to 8 hours after each dose is essential.
  • A blocked or runny nose reduces absorption; switch to tablets if you have a cold or allergies.

All patients: monitor serum sodium, particularly in the first 2 weeks and after any dose change. Symptoms of low sodium — headache, nausea, confusion, seizures — require immediate medical attention.

Side Effects

Common:

  • Headache
  • Nausea, abdominal discomfort
  • Dry mouth (uncommon despite the antidiuretic effect)
  • Flushing
  • Nasal irritation, rhinitis, epistaxis (nasal spray)

Uncommon but important — hyponatraemia and water intoxication:

The main serious risk of desmopressin is dilutional hyponatraemia — low sodium caused by water retention when fluids are not restricted. Early symptoms are headache, nausea, weight gain, and lethargy. Severe hyponatraemia can cause seizures and coma. Prevention: strict fluid restriction around each dose. Risk is highest in older adults, those on SSRIs, NSAIDs, or thiazides, and during acute illness.

Other uncommon: hypersensitivity, conjunctival inflammation, small increases in blood pressure.

Drug Interactions

  • Drugs that cause water retention or SIADH-like effects — SSRIs, tricyclic antidepressants, carbamazepine, oxcarbazepine, chlorpromazine, NSAIDs. Raise hyponatraemia risk; careful sodium monitoring.
  • Loop diuretics (furosemide) — may cause rapid sodium shifts; use with caution.
  • Thiazide diuretics — amplify hyponatraemia risk.
  • Loperamide — can markedly raise oral desmopressin levels; avoid combining.
  • Glucocorticoids — reduce desmopressin effect.

Who Should Not Take Minirin Nasal Spray?

  • Current or history of hyponatraemia
  • SIADH (syndrome of inappropriate antidiuretic hormone secretion)
  • Moderate-to-severe renal impairment (creatinine clearance < 50 mL/min)
  • Heart failure or other conditions requiring diuretic treatment
  • Polydipsia (habitual excessive thirst/drinking)
  • Known hypersensitivity to desmopressin
  • Nasal spray specifically: chronic rhinitis, damaged nasal mucosa, unreliable absorption
  • Use with caution in older adults (increased hyponatraemia risk); some regulators advise against desmopressin for nocturia in adults > 65

Storage

Store Minirin Nasal Spray below 25°C in a dry place (tablets) or at 2–8°C until first use, then below 25°C once opened (nasal spray). Keep out of reach of children. Check specific label for expiry and in-use duration.

Frequently Asked Questions

Is desmopressin the same as a medicine for type 2 diabetes?

No. Desmopressin treats diabetes insipidus (a hormone/water-balance problem) and bedwetting/nocturia. It does not lower blood sugar and is not used for type 2 diabetes. The two conditions share only the word “diabetes”.

How much water can I drink while taking Minirin Nasal Spray?

Restrict fluids from 1 hour before to 8 hours after each dose. The exact amount depends on body size and climate, but most patients are advised to drink only when thirsty during this window and to stop drinking earlier if urine output does not increase. Never “force fluids” on desmopressin — this is the commonest cause of hyponatraemia.

What if I get a headache, nausea, or confusion on Minirin Nasal Spray?

These may be early signs of hyponatraemia. Stop the drug, stop drinking, and seek medical attention. A blood sodium test will confirm. Severe hyponatraemia can cause seizures and is a medical emergency.

Can I take Minirin Nasal Spray for bedwetting?

Yes, in children aged 6 and over and in adults with persistent primary nocturnal enuresis, desmopressin is a standard treatment — tablets are preferred over nasal spray for this indication. Usual dose: 0.2 mg at bedtime (titrate up to 0.4 mg if needed). Strict fluid restriction in the evening is essential.

Can older adults take Minirin Nasal Spray?

With caution. Adults > 65 have a significantly higher risk of hyponatraemia on desmopressin, and some regulators (including the UK MHRA) advise against using it for nocturia in this age group. If used, start at the lowest dose and monitor sodium closely.

Where can I buy Minirin Nasal Spray online?

You can order Minirin Nasal Spray (0.1 mg/mL intranasal) from MedsBase in packs of 1 or 3 bottles (2.5 mL each). We ship worldwide, with discreet packaging and genuine Ferring Pharmaceuticals manufacturer stock.

Related Medications

⚕ Medical Disclaimer. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Desmopressin carries a serious risk of hyponatraemia (low sodium) — always use under medical guidance with fluid restriction and periodic sodium monitoring. Stop immediately and seek medical attention if you develop headache, nausea, or confusion.

Related Alternatives

Other products in Chronic Conditions that customers also view:

More options in Diabetes

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

0.1mg/ml

Quantity

1 Vial/s, 2 Vial/s, 3 Vial/s, 6 Vial/s

Κριτικές

Δεν υπάρχουν ακόμη κριτικές

Προσθήκη κριτικής
Minirin Nasal Spray Minirin Nasal Spray
Αξιολόγηση*
0/5
* Η αξιολόγηση είναι υποχρεωτική
* Η απάντηση είναι υποχρεωτική
Η κριτική σας
* Η κριτική είναι υποχρεωτική
Όνομα
* Απαιτείται όνομα
Προσθέστε φωτογραφίες ή βίντεο στην κριτική σας

Ερωτήσεις & Απαντήσεις

Κάντε μια ερώτηση
Minirin Nasal Spray Minirin Nasal Spray
Η ερώτησή σας
* Απαιτείται ερώτηση
Όνομα
* Απαιτείται όνομα
Δεν υπάρχουν ακόμα ερωτήσεις